Recent Progress and Future Directions of Interventional Cardiology

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 30 October 2024 | Viewed by 946

Special Issue Editor


E-Mail Website
Guest Editor
Department of Cardiology, University Hospital Galway, University of Galway, Galway, Ireland
Interests: coronary artery disease; coronary imaging; coronary physiology; plaque modification; valvular heart disease; aortic stenosis; renal denervation; robotically assisted percutaneous coronary interventions

Special Issue Information

Dear Colleagues,

I feel honored to serve as Guest Editor for this Special Issue aimed at covering Recent Progress and Future Directions of Interventional Cardiology.

From the first percutaneous coronary intervention (PCI) by Andreas Grüntzig in 1977 to patients undergoing robotically assisted PCI within the EVOLUTION study in 2023, interventional cardiology has seen many technical and clinical innovations. We are now well able to tailor physiology and intravascular-imaging-guided interventions to individual needs and to improve patient outcomes following evidence-based algorithms. Alain Cribier’s first transcatheter aortic valve implantation in 2002, followed by the PARTNER and EVOLUT trials, established TAVI as the standard of care in high-risk patients with severe aortic stenosis. With growing evidence of the good performance of TAVI-prostheses in intermediate and low-risk patients, advancements towards future trials such as the EXPAND II trial will show whether or not early intervention may further improve patient outcomes. With more and more devices for the treatment of tricuspid and mitral valve disease, the “winner of the race” is yet to be defined.

In the thriving and fast-paced field of interventional cardiology, I am excited to invite you to submit your original research or state-of-the-art reviews helping the scientific community to obtain a comprehensive overview on current and future directions in the interventional treatment of coronary and structural heart disease. Manuscripts should be motivated by innovation and research aimed at optimising treatment strategies, driving technical evolution and last but not least improving patient outcomes.

I am truly looking forward to your submissions.

Dr. Max Wagener
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • coronary artery disease
  • structural heart disease
  • PCI
  • TAVI
  • recent progress
  • future directions
  • cardiovascular outcomes

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

17 pages, 1941 KiB  
Review
Features and Limitations of Robotically Assisted Percutaneous Coronary Intervention (R-PCI): A Systematic Review of R-PCI
by Max Wagener, Yoshinobu Onuma, Ruth Sharif, Eileen Coen, William Wijns and Faisal Sharif
J. Clin. Med. 2024, 13(18), 5537; https://doi.org/10.3390/jcm13185537 - 19 Sep 2024
Viewed by 631
Abstract
Background: Ischaemic heart disease is one of the major drivers of cardiovascular death in Europe. Since the first percutaneous coronary intervention (PCI) in 1977, developments and innovations in cardiology have made PCI the treatment of choice for stenotic coronary artery disease. To address [...] Read more.
Background: Ischaemic heart disease is one of the major drivers of cardiovascular death in Europe. Since the first percutaneous coronary intervention (PCI) in 1977, developments and innovations in cardiology have made PCI the treatment of choice for stenotic coronary artery disease. To address the occupational hazards related to chronic exposure to radiation and wear and tear from heavy lead-based radioprotective aprons, the concept of robotically assisted PCI (R-PCI) was introduced in 2005. Aim: To explore the features and limitations of R-PCI, we first discuss the concept and evolution of R-PCI platforms and then systematically review the available clinical data. Methods: A systematic review has been performed across the Pubmed, Embase and Cochrane databases in order to assess the efficacy and safety of R-PCI. Secondary endpoints, such as operator and patient exposure to radiation, contrast volume used and procedural time, were assessed when available. Results: In selected patients, R-PCI provides high technical and clinical success rates, ranging from 81 to 98.8% and from 93.3 to 100%, respectively. In-hospital and 1-year MACE rates ranged from 0 to 10.4% and 4.8 to 10.5%, respectively. R-PCI is able to significantly reduce the operator’s exposure to radiation. Further research analysing the patient’s and cath lab staff’s exposure to radiation is needed. Therapy escalation with R-PCI seems to be limited to complex lesions. R-PCI procedures add approximately 10 min to the procedural time. Conclusions: The efficacy and safety of R-PCI have been proven, and R-PCI is able to significantly reduce occupational hazards for the first operator. The lack of adoption in the community of interventional cardiologists may be explained by the fact that current generations of R-PCI platforms are limited by their incompatibility with advanced interventional devices and techniques needed for escalation in complex interventions. Full article
(This article belongs to the Special Issue Recent Progress and Future Directions of Interventional Cardiology)
Show Figures

Figure 1

Back to TopTop